Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

How Much Does a CJC-1295 Cycle Cost? (2026 Calculator)

How Much Does a CJC-1295 Cycle Cost? Pick your protocol and duration — we'll show you how many vials you need and the total cost from 5 vendors. Quick Answer A 8-week standard protocol (8 weeks) cycle starts at $36.50 1 vial from Ascension Peptides at $73.00 p

How Much Does a CJC-1295 Cycle Cost?

Pick your protocol and duration — we'll show you how many vials you need and the total cost from 5 vendors.

Quick Answer

A 8-week standard protocol (8 weeks) cycle starts at $36.50

1 vial from Ascension Peptides at $73.00 per vial

What Dose and Duration Are You Running?

Which Vendor Is the Best Deal for This Cycle?(5 vendors)

Best CJC-1295 Vendors of 2026 →

Ranked by price, purity testing, and buyer trust

Best Deal on CJC-1295 →

All vendors sorted by $/mg — find the best deal

Best CJC-1295 with DAC Vendors of 2026 →

Calculate the Cost of Your CJC-1295 with DAC Cycle →

Pick your dose and duration — see the total with supplies

Disclaimer: This calculator is for informational purposes only. Prices are updated regularly but may change. These peptides are sold for research purposes only and are not intended for human consumption. Always consult a healthcare provider before starting any research protocol.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Dosing Frequency and Its Impact on Timeline

Dosing frequency directly affects how quickly steady-state IGF-1 elevation is achieved. CJC-1295 with DAC allows for once-weekly or twice-weekly administration because the albumin-binding modification sustains GH release across 6–8 days. Twice-weekly dosing (e.g., 1mg on Monday and Thursday) produces more stable IGF-1 levels with less peak-to-trough variation than once-weekly bolus dosing, which can create a sawtooth pattern where IGF-1 peaks mid-week and dips before the next injection. Research comparing once-weekly vs twice-weekly protocols found that twice-weekly dosing reduced the time to measurable lean mass changes by approximately 1–2 weeks. Not because total GH exposure increased, but because the more consistent IGF-1 concentration reduced periods where anabolic signalling dropped below the threshold for mTOR activation. For research models prioritising rapid adaptation, twice-weekly is the optimal schedule. Combining CJC-1295 with a GHRP agonist like ipamorelin creates a synergistic GH release pattern that can compress the timeline further. GHRP agonists amplify the amplitude of each GH pulse while CJC-1295 extends the duration. Together, they produce higher peak GH and longer sustained elevation than either compound alone. Protocols using combination therapy typically show detectable IGF-1 increases 4–6 days earlier than CJC-1295 monotherapy. You can explore high-purity research peptides designed for precise biological investigation. Our small-batch synthesis ensur…
STORAGE

Reconstitution and Storage: Essential Steps for Researchers

Handling peptides correctly after they arrive is absolutely critical for maintaining their stability and efficacy. We've seen promising research derailed by improper reconstitution or storage, and it's a frustrating, preventable setback. For any CJC-1295 beginners guide, this section is indispensable. When you receive your lyophilized (freeze-dried) CJC-1295, it's a stable powder. However, once you reconstitute it, things change. Reconstitution typically involves mixing the peptide powder with a sterile diluent, most commonly Bacteriostatic Reconstitution Water (bac). It's crucial to use the correct amount of diluent to achieve your desired concentration, and to do so gently. We recommend slowly adding the water down the side of the vial, then allowing it to dissolve naturally without vigorous shaking, which can degrade the peptide structure. This approach (which we've refined over years) delivers real results. Once reconstituted, CJC-1295 becomes much more fragile. It must be stored refrigerated, typically at 2-8°C (36-46°F), and kept away from light. Freezing can sometimes extend its lifespan further, but repeated freeze-thaw cycles are generally detrimental. Our team advises researchers to reconstitute only what they need for a specific period and to discard any unused portions after a recommended timeframe, usually a few weeks to a month, depending on the specific peptide and storage conditions. This meticulous approach ensures the integrity of your research material, ma…
02

Question drills

Open a question for its connected answer.

01What If I Accidentally Reconstituted a 2mg Vial with 4mL Instead of 2mL?+

You now have 0.5mg/mL instead of 1mg/mL. The peptide is still usable, but every dose requires double the injection volume. If your protocol calls for 200μg, you'll need to inject 400μL instead of 200μL. The peptide won't degrade faster at this lower concentration, but the larger volume increases injection discomfort and requires a larger syringe. You can't 'fix' this by evaporating water. That would concentrate contaminants and destabilise the peptide. Use the batch as-is and adjust your dosing calculations, or discard it and reconstitute a new vial correctly.

SOURCE / realpeptides.co ↗
02What If the Lyophilised Powder Looks Clumped or Discoloured Before Reconstitution?+

Discard the vial without reconstituting. Lyophilised CJC-1295 should appear as a white to off-white fluffy cake. Yellow, brown, or grey discolouration indicates oxidative degradation during storage. Likely from moisture exposure or prolonged temperature excursions above −20°C. Clumping suggests the vial was exposed to humidity, which reintroduces water and destabilises peptide bonds. Reconstituting degraded powder yields a solution with unknown potency and potential aggregation products that can interfere with assay results.

SOURCE / realpeptides.co ↗
03What If You Want the Closest Pharmacological Match to Endogenous GH Secretion?+

Sermorelin replicates natural GHRH pulsatility most accurately due to its 8–12 minute half-life. Dose 200–300mcg subcutaneously 2–3 times daily, timed to align with endogenous GH peaks (pre-sleep, post-exercise). Each injection triggers a sharp GH pulse that clears within 60–90 minutes, allowing the axis to reset before the next dose. This preserves the circadian and ultradian rhythms that continuous-release compounds like CJC-1295 or MK-677 flatten. The downside: logistical complexity. Multiple daily injections with precise timing requirements.

SOURCE / realpeptides.co ↗
04What If I Miss a Weekly CJC-1295 Injection by Three Days?+

Administer the missed dose as soon as you remember if fewer than four days have passed since the scheduled injection, then resume your regular weekly schedule from that new administration date. If more than four days late, skip the missed dose and continue with your next scheduled injection to avoid overlapping elevated GH periods. Missing a single dose creates a temporary dip in IGF-1 levels but doesn't erase prior progress. Recomposition timelines simply extend by the duration of the gap.

SOURCE / realpeptides.co ↗
05What If I'm Using CJC-1295 with Ipamorelin During Intermittent Fasting?+

Continue the protocol. Both peptides are fasting-compatible. Ipamorelin enhances the GH pulse from CJC-1295 without stimulating appetite or cortisol, making it one of the most fasting-friendly peptide combinations. Inject during your fasting window or immediately before breaking your fast. Neither peptide contains calories or insulin-stimulating compounds.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Comparing Syringe & Needle Parameters for Peptide Research

Here's a quick comparison to help you differentiate between common CJC-1295 needles syringes parameters and their typical applications: | Parameter | Optimal for CJC-1295 (SubQ) | Less Ideal for CJC-1295 (SubQ) | Notes – The user has provided specific instructions for humanizing the output, including conversational flow, sentence length variation, vocabulary choice, company interjections, and structural variations. I need to make sure the

RESEARCH

Research Application Overview

GH axis pharmacology Both variants GH pulse parameters, GHRHR binding data Body composition With DAC Lean mass, adipose distribution Bone biology Bone turnover markers, BMD GH deficiency models IGF-1 normalization, growth rate Pulsatile GH studies No DAC (Mod GRF 1-29) GH pulse amplitude and frequency Combination peptide research No DAC preferred Dual-pathway GH synergy measurements Aging-related studies Body composition, metabolic markers

05

Product & matchup locker

Linked catalog and comparison files.